Cingulate Inc. (CING)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $4.26
- As of
Kresmion compiles this page from CING's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Cingulate Inc. (CING): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-02.
See the full CING dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CING on one page. Preview it with sample data, then open it live with a free account.
Preview the CING dossierActive events for CING
- high13F: funds added
3 tracked funds increased CING this 2026Q2, institutional consensus
- mediumEarnings above estimates
Q2-2026: Beat consensus by 29.4%, EPS $-0.45 vs $-0.6375 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in CING
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +300% to CING (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in CING
FREE, NO ACCOUNT
Every event on CING, as it fires
You are seeing 5 of 9 events recorded on CING since 2026-05-30.
The five above landed across 4 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CING positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 17248W303 · 2026Q2 | $697K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CING
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CING's 10-Q filed Aug 13, 2026 states:
These uncertainties raise substantial doubt about our ability to continue as a going concern for one year after the issuance date of our financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CING
CING against its peers
CING's return on equity of -894.8% ranks in the 8th percentile of 17 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-04-30.
| Metric | CING | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 2.8M | n/a | 12 |
| Operating margin | n/a | -352.2% | n/a | 11 |
| Net margin | n/a | -377.8% | n/a | 12 |
| Return on equity | -894.8% | -68.5% | 8 | 17 |
Peers (22): ACRV, OKYO, CRDF, SMNR, CRBP, MNOV, TENX, NTRB, NRXS, CSBR, ATRA, COYA, MAIA, GOSS, GNLX, KLRS, PLYX, CGTX, KZIA, TNYA, RLYB, FBIO. Left out: CNXU (no annual filing), TELO (no annual filing), TLSA (period gap). Fiscal periods ending between 2025-03-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (CING: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CING on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CING in the last 180 days.
Upstream: SEC EDGAR filings for CING
Kresmion, "Cingulate Inc. (CING) institutional holdings and SEC filings", data as of 2026-10-02, https://kresmion.com/research/CING. Upstream data: SEC EDGAR filings for CING.
Link to this data (HTML):
<a href="https://kresmion.com/research/CING">Cingulate Inc. (CING) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CING on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CING for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.